Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Combination therapy of doxifluridine (5'-DFUR) + cyclophosphamide (CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].
Ota J, Taguchi T, Sakai K, Irie K, Terasawa T, Shimoyama T, Kawahara T, Okumura T, Yamamoto M, Yasutake K, et al. Ota J, et al. Among authors: terasawa t. Gan To Kagaku Ryoho. 1992 Aug;19(9):1279-84. Gan To Kagaku Ryoho. 1992. PMID: 1386974 Clinical Trial. Japanese.
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H, Sakai K, Oka T, Ozawa K, Saito Y, Senoo T, Taguchi T, Terasawa T, Nakao K, Mori T, Koyama H, Oshima A. Inaji H, et al. Among authors: terasawa t. Gan To Kagaku Ryoho. 2006 Oct;33(10):1423-9. Gan To Kagaku Ryoho. 2006. PMID: 17033231 Clinical Trial. Japanese.
[Clinical evaluation of adriamycin in advanced and recurrent breast cancer (No. 4)--Joint study by 30 institutes on the duration of remission using various maintenance therapies in patients treated with CAF. Clinical Study Group of Adriamycin for Breast Cancer in Japan].
Nomura Y, Abe O, Izuo M, Inoue K, Enomoto K, Kubo K, Koyama H, Sakai K, Terasawa T, Tominaga T. Nomura Y, et al. Among authors: terasawa t. Gan To Kagaku Ryoho. 1988 Jun;15(6):1863-71. Gan To Kagaku Ryoho. 1988. PMID: 3382238 Japanese.
[Combination therapy of high dose doxifluridine (5'-DFUR)+mitomycin C (MMC) for advanced or recurrent colorectal cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].
Kikkawa N, Taguchi T, Sakai K, Irie K, Terasawa T, Shimoyama T, Iwanaga T, Fukuda I, Okumura S, Yasutake K, et al. Kikkawa N, et al. Among authors: terasawa t. Gan To Kagaku Ryoho. 1993 Jan;20(1):117-23. Gan To Kagaku Ryoho. 1993. PMID: 8422175 Japanese.
A randomized trial comparing ftorafur alone with ftorafur plus tamoxifen in postoperative adjuvant therapy for breast cancer. Kinki Area Research Group for Postoperative Adjuvant Therapy for Breast Cancer.
Sakai K, Kosaki G, Seno T, Taguchi T, Terasawa T, Nakao K, Koyama H, Oshima A. Sakai K, et al. Among authors: terasawa t. Cancer Chemother Pharmacol. 1996;37(6):587-92. doi: 10.1007/s002800050433. Cancer Chemother Pharmacol. 1996. PMID: 8612314 Clinical Trial.
307 results